Loading...
The effect of thymosin α1 on mortality of critical COVID-19 patients: A multicenter retrospective study
BACKGROUND: Thymosin α1 therapy was commonly used in patients with coronavirus disease 2019 (COVID-19), while its impact on outcomes and which patients could benefit from thymosin α1 therapy were uncertain. STUDY DESIGN AND METHODS: Patients with COVID-19 from 19 designated hospitals between January...
Na minha lista:
| Udgivet i: | Int Immunopharmacol |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier B.V.
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7604217/ https://ncbi.nlm.nih.gov/pubmed/33208294 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.intimp.2020.107143 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|